메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Pictor's Test Poised to Transform Hepatitis B Immunity Testing…

CARLSBAD, Calif., Dec. 19, 2025 -- With the CDC's Advisory Committee on Immunization Practices (ACIP) recommending post-vaccination antibody testing for hepatitis B, laboratories are facing new demands to assess immunity more effectively. Pictor, a leader in targeted proteomics, today highlighted its ViraScreen-Core™ multiplex antibody assay, an established test already in use by CLIA-certified laboratories, as a ready solution to support this evolving public health guidance. Built for both serum and saliva, the assay offers unmatched flexibility for labs adapting to these changes whi
- 김갑성 기자
- 2025-12-19 22:17
VARON Enhances Customer Access to Oxygen Concentrator…

NEW YORK, Dec. 19, 2025 -- As more individuals, families, and caregivers research oxygen therapy solutions online, knowing where to buy a reliable oxygen concentrator has become an important part of the decision-making process. With increasing demand for clear product information, authentic devices, and dependable after-sales support, VARON continues to strengthen customer access through its official online store. By purchasing directly from the VARON official website, customers can explore a complete range of oxygen concentrators for home and portable use, suppor
- 김갑성 기자
- 2025-12-19 19:52
WuXi Biologics Achieves CDP Highest "A" Ratings in Both Climate…

SHANGHAI, Dec. 19, 2025 -- WuXi Biologics (2269.HK) announced that it has been named to the CDP "A" lists for both Climate Change and Water Security for 2025, underscoring its leadership in environmental stewardship and transparent disclosure. Climate Change Leadership Being recognized with an "A" rating by CDP for Climate Change affirms WuXi Biologics' leadership in environmental performance. The company's integrated climate change strategy – which has been validated by SBTi – is anchored in a clear goal of achieving net-zero emissions across its value chain
- 김갑성 기자
- 2025-12-19 17:30
Prepare for a Healthier Holiday Season with Wellness Tips fro…

MANILA, Philippines , Dec. 19, 2025 -- As the holiday season begins to unfold in the Philippines, families are starting to plan gatherings, reunions, and early celebrations. For households with elderly relatives or loved ones managing respiratory conditions such as COPD, asthma or other breathing difficulties, this period of increased activity can bring added considerations for health and comfort. VARON Philippines highlights the importance of respiratory wellness during the holidays, noting that home oxygen concentrators offer reliable support at home, while port
- 김갑성 기자
- 2025-12-19 13:48
SG-based Startup Galatek Raises $30M Series A to Accelerate…

SINGAPORE, Dec. 19, 2025 -- Galatek, a fast-growing Singapore-based automation and artificial intelligence (AI) startup, announced today that it has secured approximately US$30 million in Series A funding. The funding will accelerate the company's development of innovative products in life sciences and advanced semiconductor manufacturing, strengthen its global supply chain, and deepen local expertise in key markets across Europe, North America, and Southeast Asia. As AI continues to accelerate digital transformation across industries, Galatek addresses critical challenges in life scie
- 김갑성 기자
- 2025-12-19 10:47
NEW DRUG APPLICATION FOR TINENGOTINIB TABLETS ACCEPTED BY THE…

[ 메디채널 김갑성 기자 ] NANJING, China and GAITHERSBURG, Md., Dec. 19, 2025 -- TransThera Sciences Nanjing, Inc. (the "TransThera") announced that the new drug application for Tinengotinib tablets has been accepted by the Center for Drug Evaluation ("CDE")of the National Medical Products Administration ("NMPA") of the PRC. It is intended for the treatment of adults with unresectable advanced or metastatic cholangiocarcinoma (CCA) who have received at least one prior systemic treatment and FGFR inhibitor treatment. Previously, Tinengotinib tablets have been included in
- 김갑성 기자
- 2025-12-19 09:46
NGT Launches Wellness Campaign with JOGUMAN…Unveils Fo…

SEOUL, South Korea, Dec. 19, 2025 -- Natural Good Things (NGT), a women's inner-care brand, has partnered with JOGUMAN—an IP managed globally by IPX (formerly LINE FRIENDS)—to launch its new wellness campaign, "Small but Healthy." Through the meeting, NGT has introduced four special-edition products. NGT is a wellness brand equipped with its own R&D capabilities and ingredient manufacturing system, producing and distributing health-functional raw materials in-house. The brand has grown by focusing on products that support women's daily health routines. Its flagship produc
- 김갑성 기자
- 2025-12-19 09:19
MEDIPOST Announces the Exclusive Commercialization Licen…

- South Korean biotech company secures US$8 million in upfront payment for the joint commercialization of the stem cell therapy CARTISTEM® targeting the Japanese knee osteoarthritis market. SEOUL, South Korea, Dec. 19, 2025 -- MEDIPOST Co., Ltd. (KOSDAQ 078160), a fully integrated cell therapy biotechnology company, today announced a multi-year partnership with Japan's Teikoku Seiyaku Co., Ltd. for the commercialization of CARTISTEM®, an innovative treatment for knee osteoarthritis, in the Japanese market. Under the terms of the agreement, MEDIPOST K.K. (MEDIPOST
- 김갑성 기자
- 2025-12-19 08:39
Corti Unlocks "Surgical" AI Improvement, Outperforming Big Tech…

[ 메디채널 김갑성 기자 ] New "GIM" method tops MIB global leaderboard, offering the industry a scalable way to inspect and improve billion-parameter models. COPENHAGEN, Denmark and NEW YORK, Dec. 19, 2025 -- Corti, a healthcare AI infrastructure company, today announced a major advance in AI transparency, achieving the #1 position on the Hugging Face Mechanistic Interpretability Benchmark (MIB). The benchmark, maintained by researchers from MIT, Stanford, Cambridge, Boston, and ETH Zurich, is the industry standard for evaluating interpretability methods. By outperforming esta
- 김갑성 기자
- 2025-12-19 05:12
Neuraxpharm Goes Live with TraceLink MINT to Standardize R…

The European specialty pharmaceutical company establishes a unified digital data foundation to enable future agentic orchestration BOSTON, Dec. 18, 2025 -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced that Neuraxpharm, a European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, has gone live on the TraceLink network with Multienterprise Information Network Tower (MINT), powered by Orchestration Platform for Universal Solutions (OPUS). The C
- 김갑성 기자
- 2025-12-19 00:02

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2026-01-31_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 31일 17시 40분